167 related articles for article (PubMed ID: 37031423)
1. Differentiated thyroid cancer: Case report of false positive
Giannoula E; Koutsouki G; Exadaktylou P; Papadopoulos N; Papanastasiou E; Doumas A; Iakovou I
Hell J Nucl Med; 2023; 26(1):66-69. PubMed ID: 37031423
[TBL] [Abstract][Full Text] [Related]
2. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
3. False positive diagnosis on (131)iodine whole-body scintigraphy of differentiated thyroid cancers.
Triggiani V; Giagulli VA; Iovino M; De Pergola G; Licchelli B; Varraso A; Dicembrino F; Valle G; Guastamacchia E
Endocrine; 2016 Sep; 53(3):626-35. PubMed ID: 26499192
[TBL] [Abstract][Full Text] [Related]
4. Combined BRAF
Campennì A; Ruggeri RM; Siracusa M; Pignata SA; Di Mauro F; Vento A; Trimarchi F; Baldari S
J Endocrinol Invest; 2018 Nov; 41(11):1283-1288. PubMed ID: 29549631
[TBL] [Abstract][Full Text] [Related]
5. RADIOISOTOPE DIAGNOSTIC ALGORITHM FOR THE RELAPSE AND METASTASES DETECTION IN THE IODINE-NEGATIVE DIFFERENTIATED THYROID CANCER.
Solodyannikova OI; Kmetyuk YV; Danilenko VV; Sukach GG
Probl Radiac Med Radiobiol; 2020 Dec; 25():579-591. PubMed ID: 33361863
[TBL] [Abstract][Full Text] [Related]
6. Our solution for fusion of simultaneusly acquired whole body scintigrams and optical images, as usesful tool in clinical practice in patients with differentiated thyroid carcinomas after radioiodine therapy. A useful tool in clinical practice.
Matovic M; Jankovic M; Barjaktarovic M; Jeremic M
Hell J Nucl Med; 2017; 20 Suppl():159. PubMed ID: 29324929
[TBL] [Abstract][Full Text] [Related]
7. MRI versus ¹³¹I whole-body scintigraphy for the detection of lymph node recurrences in differentiated thyroid carcinoma.
Mihailovic J; Prvulovic M; Ivkovic M; Markoski B; Martinov D
AJR Am J Roentgenol; 2010 Nov; 195(5):1197-203. PubMed ID: 20966328
[TBL] [Abstract][Full Text] [Related]
8. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-EDDA/HYNIC-TOC in the diagnosis of differentiated thyroid carcinoma refractory to radioiodine treatment.
Czepczyński R; Gryczyńska M; Ruchała M
Nucl Med Rev Cent East Eur; 2016; 19(2):67-73. PubMed ID: 27479883
[TBL] [Abstract][Full Text] [Related]
10. Value of technetium scintigraphy and iodine uptake measurement during follow-up of differentiated thyroid cancer.
Caglar M; Tuncel M; Alpar R
Ann Nucl Med; 2004 Sep; 18(6):479-82. PubMed ID: 15515746
[TBL] [Abstract][Full Text] [Related]
11. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
12. A false-positive I-131 finding of duodenum diverticulum in thyroid cancer evaluation by SPECT/CT: A case report.
Wang R; Zhou K; Fan Q; Chen H; Fan C
Medicine (Baltimore); 2018 Feb; 97(8):e9997. PubMed ID: 29465605
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine Uptake at Suture Site Granuloma Mimicking Neck Node Metastasis on 131 I Whole-Body Iodine Scintigraphy.
Singh P; Agrawal K; Patel RK; Patro PSS; Parida GK
Clin Nucl Med; 2024 Jun; 49(6):e301-e303. PubMed ID: 38598541
[TBL] [Abstract][Full Text] [Related]
14. Low correlation between serum thyroglobulin and
Thai JN; De Marchena IR; Nehru VM; Landau E; Demissie S; Josemon R; Peti S; Brenner AI
Clin Imaging; 2022 Jul; 87():1-4. PubMed ID: 35439719
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the relationship between chosen factors and results of whole body scintigraphy with 131I in patients with differentiated thyroid cancers].
Mielcarek W; Dziuk E; Konieczna M; Kowalczyk A; Siekierzyński M
Wiad Lek; 2001; 54 Suppl 1():363-7. PubMed ID: 12182050
[TBL] [Abstract][Full Text] [Related]
16. False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer.
Oh JR; Ahn BC
Am J Nucl Med Mol Imaging; 2012; 2(3):362-85. PubMed ID: 23133823
[TBL] [Abstract][Full Text] [Related]
17. False-positive iodine-131 whole-body scan findings in patients with differentiated thyroid carcinoma: report of 11 cases and review of the literature.
Buton L; Morel O; Gault P; Illouz F; Rodien P; Rohmer V
Ann Endocrinol (Paris); 2013 Jul; 74(3):221-30. PubMed ID: 23796008
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-pertechnetate whole-body SPET/CT scan in thyroidectomized differentiated thyroid cancer patients is a useful imaging modality in detecting remnant thyroid tissue, nodal and distant metastases before
Lou K; Gu Y; Hu Y; Wang S; Shi H
Hell J Nucl Med; 2018; 21(2):121-124. PubMed ID: 30089313
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine Imaging for Differentiated Thyroid Cancer: Not All Radioiodine Images Are Performed Equally.
Van Nostrand D
Thyroid; 2019 Jul; 29(7):901-909. PubMed ID: 31184275
[No Abstract] [Full Text] [Related]
20. Orbital Radioiodine Uptake in Epithelial Conjunctival Inclusion Cyst on Scintigraphy in a Patient With Differentiated Thyroid Cancer.
Makarewicz M; Skierkowski W; Makarewicz J
Clin Nucl Med; 2023 Aug; 48(8):e382-e384. PubMed ID: 37220222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]